Clustering according to urolithin metabotype explains the interindividual variability in the improvement of cardiovascular risk biomarkers in overweight-obese individuals consuming pomegranate: A randomized clinical trial

GONZALEZ-SARRIAS, ASIM; GARCIA-VILLALBA, Rocio; ROMO-VAQUERO, Maria; ALAŞALVAR, Cesarettin; Orem, Asimo; ZAFRILLA, Pilar; TOMAS-BARBERAN, Francisco; SELMA, Maria; CARLOS ESPIN, Juan

doi:10.1002/mnfr.201600830

Clustering according to urolithin metabotype explains the interindividual variability in the improvement of cardiovascular risk biomarkers in overweight-obese individuals consuming pomegranate: A randomized clinical trial

Atıf İçin Kopyala

GONZALEZ-SARRIAS A., GARCIA-VILLALBA R., ROMO-VAQUERO M., ALAŞALVAR C., Orem A., ZAFRILLA P., ...Daha Fazla

MOLECULAR NUTRITION & FOOD RESEARCH, cilt.61, sa.5, 2017 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 61 Sayı: 5
Basım Tarihi: 2017
Doi Numarası: 10.1002/mnfr.201600830
Dergi Adı: MOLECULAR NUTRITION & FOOD RESEARCH
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Anahtar Kelimeler: Cardiometabolic, EFSA, Gut microbiota, Metabotype, Urolithins, METABOLIC SYNDROME, DOUBLE-BLIND, MICROBIOTA, ELLAGITANNINS, CONSUMPTION, ANTIOXIDANT, LDL, MEN, METAANALYSIS, PREVENTION
Karadeniz Teknik Üniversitesi Adresli: Evet

Özet

Scope: The pomegranate lipid-lowering properties remain controversial, probably due to the interindividual variability in polyphenol (ellagitannins) metabolism.